Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yanqiao Ren

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Cancer Management and Research|July 15, 2021
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular CarcinomaWeihua Zhang, Lei Chen, Yanyan Cao, et al.
The British Journal of Radiology|August 27, 2024
Drug-eluting bead transarterial chemoembolization combined with apatinib/camrelizumab for the treatment of advanced hepatocellular carcinoma with hepatic arterioportal shuntsYanqiao Ren, Bo Sun, Licheng Zhu, et al.
BMC Cancer|July 15, 2026
FOLFOX-HAIC plus regorafenib for the treatment of unresectable colorectal liver metastases refractory to first and second-line systemic chemotherapyJiacheng Liu, Songlin Song, Wei Yao, et al.
Frontiers in Molecular Biosciences|December 21, 2020
Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With ApatinibTao Sun, Yanqiao Ren, Xuefeng Kan, et al.
Journal of Hepatocellular Carcinoma|March 24, 2023
The Feasibility of TACE Combined with TKIs Plus PD-1 Antibody for Advanced HCCTao Sun, Yanqiao Ren, Bo Sun, et al.
American Journal of Translational Research|February 2, 2021
Comparison of the efficacy of pre-surgery and post-surgery radiotherapy in the treatment of hepatocellular carcinoma: a population-based studyLei Chen, Xiaopeng Guo, Shi Chen, et al.
Journal of Interventional Medicine|November 22, 2021
A case of spontaneous hepatic hemangioma rupture: Successful management with transarterial chemoembolization aloneYanyan Cao, Fu Xiong, Bin Xiong, et al.
Journal of Pharmaceutical Analysis|September 12, 2024
Melatonin enhances the efficacy of anti-PD-L1 by improving hypoxia in residual tumors after insufficient radiofrequency ablationYanqiao Ren, Licheng Zhu, Yusheng Guo, et al.
Journal of Oncology|November 29, 2021
The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular CarcinomaLei Chen, Tao Sun, Linxia Wu, et al.
Journal of Oncology|March 31, 2022
A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor ThrombusTao Sun, Lei Chen, Xuefeng Kan, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Cancer Management and Research|July 15, 2021
Efficacy of Drug-Eluting Beads Transarterial Chemoembolization Plus Apatinib Compared with Conventional Transarterial Chemoembolization Plus Apatinib in the Treatment of Unresectable Hepatocellular CarcinomaWeihua Zhang, Lei Chen, Yanyan Cao, et al.
The British Journal of Radiology|August 27, 2024
Drug-eluting bead transarterial chemoembolization combined with apatinib/camrelizumab for the treatment of advanced hepatocellular carcinoma with hepatic arterioportal shuntsYanqiao Ren, Bo Sun, Licheng Zhu, et al.
BMC Cancer|July 15, 2026
FOLFOX-HAIC plus regorafenib for the treatment of unresectable colorectal liver metastases refractory to first and second-line systemic chemotherapyJiacheng Liu, Songlin Song, Wei Yao, et al.
Frontiers in Molecular Biosciences|December 21, 2020
Advanced Hepatocellular Carcinoma With Hepatic Arterioportal Shunts: Combination Treatment of Transarterial Chemoembolization With ApatinibTao Sun, Yanqiao Ren, Xuefeng Kan, et al.
Journal of Hepatocellular Carcinoma|March 24, 2023
The Feasibility of TACE Combined with TKIs Plus PD-1 Antibody for Advanced HCCTao Sun, Yanqiao Ren, Bo Sun, et al.
American Journal of Translational Research|February 2, 2021
Comparison of the efficacy of pre-surgery and post-surgery radiotherapy in the treatment of hepatocellular carcinoma: a population-based studyLei Chen, Xiaopeng Guo, Shi Chen, et al.
Journal of Interventional Medicine|November 22, 2021
A case of spontaneous hepatic hemangioma rupture: Successful management with transarterial chemoembolization aloneYanyan Cao, Fu Xiong, Bin Xiong, et al.
Journal of Pharmaceutical Analysis|September 12, 2024
Melatonin enhances the efficacy of anti-PD-L1 by improving hypoxia in residual tumors after insufficient radiofrequency ablationYanqiao Ren, Licheng Zhu, Yusheng Guo, et al.
Journal of Oncology|November 29, 2021
The Efficacy of Transarterial Chemoembolization plus Apatinib or Sorafenib in the Treatment of Advanced Hepatocellular CarcinomaLei Chen, Tao Sun, Linxia Wu, et al.
Journal of Oncology|March 31, 2022
A Comparative Analysis of Efficacy of Apatinib Combined with Transarterial Chemoembolization and Transarterial Chemoembolization Alone in the Treatment of Hepatocellular Carcinoma with Portal Vein Tumor ThrombusTao Sun, Lei Chen, Xuefeng Kan, et al.
Pageof 7